Related references
Note: Only part of the references are listed.Oleanolic Acid Reduces Hyperglycemia beyond Treatment Period with Akt/FoxO1-Induced Suppression of Hepatic Gluconeogenesis in Type-2 Diabetic Mice
Xiao-Yi Zeng et al.
PLOS ONE (2012)
Characterization of the CaMKKβ-AMPK signaling complex
Michelle F. Green et al.
CELLULAR SIGNALLING (2011)
TGR5: A Novel Target for Weight Maintenance and Glucose Metabolism
Xiaosong Chen et al.
EXPERIMENTAL DIABETES RESEARCH (2011)
Isolation and Identification of Cucurbitane-Type Triterpenoids with Partial Agonist/Antagonist Potential for Estrogen Receptors from Momordica charantia
Chin Hsu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2011)
Ca2+/Calmodulin-dependent Protein Kinase Kinase β Is Regulated by Multisite Phosphorylation
Michelle F. Green et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients
Anjana Fuangchan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2011)
Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice
Zhong Q. Wang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Structure of mammalian AMPK and its regulation by ADP
Bing Xiao et al.
NATURE (2011)
AMPK Is a Direct Adenylate Charge-Regulated Protein Kinase
Jonathan S. Oakhill et al.
SCIENCE (2011)
Puerarin activates endothelial nitric oxide synthase through estrogen receptor-dependent PI3-kinase and calcium-dependent AMP-activated protein kinase
Yong Pil Hwang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Calmodulin-dependent protein kinase kinase-β activates AMPK without forming a stable complex: synergistic effects of Ca2+ and AMP
Sarah Fogarty et al.
BIOCHEMICAL JOURNAL (2010)
Global healthcare expenditure on diabetes for 2010 and 2030
Ping Zhang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Momordica charantia Maintains Normal Glucose Levels and Lipid Profiles and Prevents Oxidative Stress in Diabetic Rats Subjected to Chronic Sucrose Load
Padmaja Chaturvedi et al.
JOURNAL OF MEDICINAL FOOD (2010)
Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice
Alexander Balhuizen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
AMPK in Health and Disease
Gregory R. Steinberg et al.
PHYSIOLOGICAL REVIEWS (2009)
Structure of the LKB1-STRAD-MO25 Complex Reveals an Allosteric Mechanism of Kinase Activation
Elton Zeqiraj et al.
SCIENCE (2009)
Berberine improves glucose metabolism through induction of glycolysis
Jun Yin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation
Jeffrey R. Erickson et al.
CELL (2008)
Thienopyridone Drugs Are Selective Activators of AMP-Activated Protein Kinase β1-Containing Complexes
John W. Scott et al.
CHEMISTRY & BIOLOGY (2008)
Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway
Min-Jia Tan et al.
CHEMISTRY & BIOLOGY (2008)
Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-Activated protein kinase and improve insulin action
Nigel Turner et al.
DIABETES (2008)
AMP-activated protein kinase subunit interactions -: β1:γ1 association requires β1 Thr-263 and Tyr-267
Tristan J. Iseli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase
Olga Goeransson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus
Shari Bolen et al.
ANNALS OF INTERNAL MEDICINE (2007)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Karen T. Liby et al.
NATURE REVIEWS CANCER (2007)
Single nucleotide polymorphism of the JWA gene is associated with risk of leukemia: A case-control study in a Chinese population
Yu-Jie Zhu et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2007)
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states
Yun S. Lee et al.
DIABETES (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases
RL Hurley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ca2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells
A Woods et al.
CELL METABOLISM (2005)
Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase
SA Hawley et al.
CELL METABOLISM (2005)
AMP-activated protein kinase β subunit tethers α and γ Subunits via its C-terminal sequence (186-270)
TJ Iseli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo
MA Iglesias et al.
DIABETES (2004)
New drug targets for type 2 diabetes and the metabolic syndrome
DE Moller
NATURE (2001)
Share Paper
